Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy.

Hall HI, Tang T, Westfall AO, Mugavero MJ.

PLoS One. 2013 Dec 31;8(12):e84318. doi: 10.1371/journal.pone.0084318. eCollection 2013.

2.

Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.

Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD.

MMWR Surveill Summ. 2011 Sep 2;60(11):1-20.

3.

Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, Gray KM, Cohen SM, Mermin J, Skarbinski J.

JAMA Intern Med. 2013 Jul 22;173(14):1337-44. doi: 10.1001/jamainternmed.2013.6841.

PMID:
23780395
4.

Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus.

Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR.

Arch Intern Med. 2008 Jun 9;168(11):1181-7. doi: 10.1001/archinte.168.11.1181.

PMID:
18541826
5.

Optimizing the use of surveillance data for monitoring the care status of persons recently diagnosed with HIV in NYC.

Sabharwal CJ, Braunstein SL, Robbins RS, Shepard CW.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):571-8. doi: 10.1097/QAI.0000000000000077.

PMID:
24326601
6.

Vital signs: HIV prevention through care and treatment--United States.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23.

7.
8.

HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions.

Cohen SM, Hu X, Sweeney P, Johnson AS, Hall HI.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):519-27. doi: 10.1097/QAI.0000000000000349.

PMID:
25230292
9.

Time to linkage to care and viro-immunologic parameters of individuals diagnosed before and after the 2006 HIV testing recommendations.

Onyeajam DJ, Eke R, Stephens TG, Duffus WA.

South Med J. 2013 Apr;106(4):257-66. doi: 10.1097/SMJ.0b013e31828d967c.

PMID:
23558414
10.

Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States.

Gray KM, Cohen SM, Hu X, Li J, Mermin J, Hall HI.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):129-32. doi: 10.1097/QAI.0000000000000028.

PMID:
24121761
11.

Monitoring outcomes for newly diagnosed and prevalent HIV cases using a care continuum created with New York city surveillance data.

Wiewel EW, Braunstein SL, Xia Q, Shepard CW, Torian LV.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):217-26. doi: 10.1097/QAI.0000000000000424.

PMID:
25394192
12.

Prevalence and indicators of viral suppression among persons with diagnosed HIV infection retained in care - Georgia, 2010.

Edison L, Hughes D, Drenzek C, Kelly J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jan 24;63(3):55-8.

13.

Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study.

Tripathi A, Gardner LI, Ogbuanu I, Youmans E, Stephens T, Gibson JJ, Duffus WA.

AIDS Care. 2011 Nov;23(11):1366-73. doi: 10.1080/09540121.2011.565032. Epub 2011 Jun 21.

PMID:
22022847
14.

Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.

Rutstein RM, Gebo KA, Flynn PM, Fleishman JA, Sharp VL, Siberry GK, Spector SA.

Med Care. 2005 Sep;43(9 Suppl):III15-22.

PMID:
16116305
15.

Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.

Jacobson LP, Li R, Phair J, Margolick JB, Rinaldo CR, Detels R, Muñoz A.

Am J Epidemiol. 2002 Apr 15;155(8):760-70.

PMID:
11943695
16.

Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.

Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, Ross MJ, Crum-Cianflone NF; Infectious Disease Clinical Research Program HIV/STI Working Group.

HIV Med. 2013 Feb;14(2):65-76. doi: 10.1111/j.1468-1293.2012.01036.x. Epub 2012 Jul 19.

17.

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.

Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ.

Ann Intern Med. 1994 Jul 15;121(2):100-8.

PMID:
8017721
18.

Vital signs: HIV testing and diagnosis among adults--United States, 2001-2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Dec 3;59(47):1550-5.

19.

Disparities in engagement in care and viral suppression among persons with HIV.

Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):112-9. doi: 10.1097/QAI.0b013e3182894555.

PMID:
23392459
20.

Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996.

Dean-Gaitor HD, Fleming PL.

AIDS. 1999 Dec 3;13(17):2429-35.

PMID:
10597785

Supplemental Content

Support Center